

![]() |
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database |
|
Authors | ![]() | |
Collaboration | With : Ribi, Camillo / Chizzolini, Carlo | |
Published in | Annals of the rheumatic diseases. 2007, vol. 66, no. 6, p. 754-63 | |
Abstract | Systemic sclerosis (SSc) is a multisystem autoimmune disease, which is classified into a diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subset according to the skin involvement. In order to better understand the vascular, immunological and fibrotic processes of SSc and to guide its treatment, the EULAR Scleroderma Trials And Research (EUSTAR) group was formed in June 2004. | |
Keywords | Adult — Age Distribution — Age of Onset — Aged — Autoantibodies/blood — Cross-Sectional Studies — Databases, Factual — Female — Humans — Male — Middle Aged — Nuclear Proteins/immunology — Raynaud Disease/etiology/immunology — Risk Assessment — Scleroderma, Diffuse/complications/immunology — Scleroderma, Limited/complications/immunology — Scleroderma, Systemic/complications/immunology — Sex Factors | |
Identifiers | PMID: 17234652 | |
Full text | ||
Structures | ||
Research group | La matrice extracellulaire (651) | |
Citation (ISO format) | WALKER, U et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. In: Annals of the rheumatic diseases, 2007, vol. 66, n° 6, p. 754-63. doi: 10.1136/ard.2006.062901 https://archive-ouverte.unige.ch/unige:73762 |